3 Pharmaceutical Companies Consolidate Brand Identity, Operations to Gain Market

Manila Bulletin, June 25, 2010 | Go to article overview

3 Pharmaceutical Companies Consolidate Brand Identity, Operations to Gain Market


Three pharmaceutical companies, each a prominent industry label, recently consolidated their brand identity and operations to be a leading provider of healthcare commercialization solutions in the Asia-Pacific region.

Invida Philippines Inc. has been launched in the Philippines specialty pharmaceutical industry through the merger of PL Asia Pacific Philippines Inc., more popularly known by its brand name Pharmalink, Transfarma Philippines Inc. and Inovail Healthcare Philippines Inc. The integrated companies were wholly-owned subsidiaries of Singapore-headquartered Invida Group Private Limited that was set up in 2005 by a powerful strategic partnership of Quintiles, the world's leading pharmaceutical services organization; a subsidiary of Temasek Holdings, one of the world's largest investment companies; and the Zuellig Group, the largest pharmaceutical distribution and supply chain management network in Asia Pacific.

The decision to unify into a single global brand will facilitate the Invida Group's entry into the market as one company," says Tito Tolentino, President of Invida Philippines. He explains further, "Currently, we have a very strong, recognized capability and core competence in the area of commercialization.

As an organization, we want to leverage on this capability even more, in order to achieve significant competitive edge in the region. We want to continue to be an integral player in the industry and a preferred partner for companies wanting to enter or extend their reach, not just locally, but also to the entire Asia Pacific market. With our vast regulatory, sales and marketing footprint across Asia Pacific, we can offer our partners a single point of entry into these markets."

Tolentino believes that as a result of the merger, "Invida has strengthened its position in the market, benefiting from the synergy of the three companies operating under a single entity."

Synergy is a byword in the pharmaceutical world. It is usually used to highlight the therapeutic efficacy of a drug preparation generated by the combined action of the individual potent agents. With the interaction of the constituents, the total effect is greater than the sum of the individual effects. Such is the power Invida sees in itself.

Pharmalink made a name for itself as Asia's leading sales and marketing organization, securing a slot in the Philippine pharmaceutical industry's top 20.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

3 Pharmaceutical Companies Consolidate Brand Identity, Operations to Gain Market
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.